Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
breast cancer
Jul 1, 2024, 23:51 |
Insight
Piotr Wysocki: Neoadjuvant therapy for renal-cell cancer patients is still in its infancy, unlike in melanoma
Piotr Wysocki recently posted on LinkedIn: "The PROSPER ECOG-ACRIN EA8143 study (published online in Lancet…
Jul 1, 2024, 16:53 |
Blog
Francine Mulenga: Speaking about breast imaging at National Hospital Abuja
Francine Mulenga, Consultant Radiographer, Breast Screening Services at University Hospitals of North Midlands NHS Trust,…
Jul 1, 2024, 13:29 |
Blog
Rodrigo Sánchez-Bayona: RWE study of ovarian cancer patients treated with PARP inhibitors at ESMO Gynaecological Cancers Congress 2024
Rodrigo Sánchez-Bayona, Medical Oncologist specialising in breast and gynecological cancers at 12 de Octubre University…
Jul 1, 2024, 12:54 |
Dialogues
ASCO24 Updates: Improving Cancer Care in Nigeria: HE Zainab Shinkafi-Bagudu
The American Society of Clinical Oncology (ASCO) Annual Meeting is one of the largest and most…
Jul 1, 2024, 03:19 |
Blog
Shahrin Ahmed: MED12 is identified as being instrumental in basal-like pancreatic cancer
Shahrin Ahmed, Medical Specialist at the Canadian Cancer Society, shared on X: "Pancreatic cancer awareness…
Jun 30, 2024, 15:08 |
Blog
Sami Mansfield: Challenges in implementing exercise oncology and cancer rehabilitation
Sami Mansfield posted on LinkedIn: "Almost every day, I hear from my oncology colleagues that…
Jun 30, 2024, 09:41 |
Insight
MD Anderson Cancer Center’s Research Highlights
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in…
Jun 29, 2024, 09:05 |
Blog
Erika Hamilton: Always worth major celebration when we see survival improve by 10 months in metastatic cancer
Erika Hamilton shared a post by Healthbook on LinkedIn, adding: "Always worth major celebration when we…
Jun 27, 2024, 13:40 |
Insight
New study on germline CDH1 variants shows lifetime cancer risks
Yüksel Ürün shared on X: "New study on germline CDH1 variants shows lifetime cancer risks:…
Jun 27, 2024, 09:01 |
Insight
Piotr Wysocki: Anti-inflammatory drugs improve outcomes of patients with early PIK3CA-mutated colorectal cancer
Piotr Wysocki recently posted on LinkedIn: "For many years, anti-inflammatory drugs, mainly aspirin and celecoxib, have…
101
102
103
104
105
All:
2632
Posts:
1021 - 1030
Inside OncoDaily Party Barcelona
Zainab Shinkafi-Bagudu has been elected as UICC President-Elect 2024-2026
Agenus CEO Dr. Garo Armen Honored with WITSA Eminent Person 2024 Award for Cancer Immunotherapy Breakthrough
Vivek Subbiah: Key publications leading to Nobel Prize 2024, published in 1993
Victor Ambros and Gary Ruvkun Awarded 2024 Nobel Prize in Medicine for MicroRNA Discovery
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube